当前位置:首页 - 行情中心 - 润达医疗(603108) - 财务分析 - 资产负债表

润达医疗

(603108)

  

流通市值:119.58亿  总市值:119.58亿
流通股本:6.04亿   总股本:6.04亿

资产负债表

报告期2024-09-302024-06-302024-03-312023-12-31
公司类型通用通用通用通用
流动资产:
货币资金1,122,807,492.891,185,357,869.251,089,560,646.761,068,061,473.28
应收票据及应收账款5,497,419,182.215,643,961,089.815,802,536,287.255,645,587,948.01
其中:应收票据115,443,260.84130,414,342.77103,179,557.12105,978,495.21
应收账款5,381,975,921.375,513,546,747.045,699,356,730.135,539,609,452.8
预付款项963,341,169.221,076,569,494.65959,390,899.74977,624,078.27
其他应收款合计183,221,944.11186,499,731.94167,784,180.73200,574,365.27
应收股利231,13318,847,036.62254,506254,506
存货1,456,897,478.751,369,711,585.151,348,472,783.361,376,953,338.75
一年内到期的非流动资产46,917,424.1542,110,068.5745,913,709.638,315,994.61
其他流动资产84,186,823.354,784,793.136,109,576.2728,783,623.59
流动资产平衡项目0000
流动资产合计9,454,391,514.639,643,994,632.479,525,768,083.719,393,900,821.78
非流动资产:
长期应收款12,163,576.5713,717,762.7315,165,293.9223,902,773.16
长期股权投资1,233,726,812.641,221,416,905.31,198,244,669.451,172,134,183.27
其他权益工具投资39,349,591.8339,349,591.8339,349,591.8339,349,591.83
固定资产1,025,907,017.07989,357,620.451,018,835,867.781,059,474,905.34
在建工程5,917,836.426,114,651.044,736,702.2418,710,477.05
使用权资产104,535,803.91110,173,066.34118,347,156131,636,172.44
无形资产78,804,891.683,906,809.1587,885,952.4576,644,985.54
开发支出7,641,504.012,046,023.65--
商誉2,011,808,358.232,011,808,358.232,011,808,358.232,011,808,358.23
长期待摊费用134,611,353.89134,245,193.48138,832,103.37142,996,969.42
递延所得税资产247,473,560.92236,753,170.82241,787,807.9234,743,455.48
其他非流动资产4,833,086.214,913,086.215,194,636.214,690,586.23
非流动资产平衡项目0000
非流动资产合计4,906,773,393.34,853,802,239.234,880,188,139.384,916,092,457.99
资产平衡项目0000
资产总计14,361,164,907.9314,497,796,871.714,405,956,223.0914,309,993,279.77
流动负债:
短期借款5,140,923,329.325,108,577,4894,889,534,736.634,711,694,456.01
应付票据及应付账款1,269,074,122.541,371,658,786.341,485,712,952.641,506,684,601.69
其中:应付票据-37,000,00091,000,000108,000,000
应付账款1,269,074,122.541,334,658,786.341,394,712,952.641,398,684,601.69
预收款项14,187,987.0218,610,396.0118,344,937.2114,622,602.87
合同负债87,043,874.8275,579,732.379,720,210.8298,586,260.68
应付职工薪酬48,512,638.4739,693,255.4748,463,708.9877,430,984.12
应交税费90,524,248.394,856,395.23138,511,679.13143,708,687.45
其他应付款合计180,845,468.88246,761,138.31152,706,428.04185,910,089.61
应付股利18,019,174.3780,844,733.976,971,219.378,807,954.37
一年内到期的非流动负债1,089,527,978.62934,414,707.03867,478,233.48777,678,767.32
其他流动负债15,533,756.5114,237,015.9914,676,864.9511,650,490.03
流动负债平衡项目0000
流动负债合计7,936,173,404.487,904,388,915.687,695,149,751.887,527,966,939.78
非流动负债:
长期借款443,166,040.02304,715,372.24411,216,469.45500,576,600
应付债券280,736,786.22595,045,136.6590,820,389.01602,045,566.56
租赁负债78,442,991.9176,827,650.7379,048,930.3588,249,217.86
长期应付款58,633,038.4440,998,977.4846,653,147.2271,657,839.06
预计负债2,294,780.62,176,307.182,261,416.112,130,454.28
递延收益11,912,209.5614,837,690.3916,174,772.6517,793,943.35
递延所得税负债43,380,976.7945,218,304.848,046,852.8151,858,928.57
其他非流动负债473,308.73473,308.73473,308.73461,016.89
非流动负债平衡项目0000
非流动负债合计919,040,132.271,080,292,748.151,194,695,286.331,334,773,566.57
负债平衡项目0000
负债合计8,855,213,536.758,984,681,663.838,889,845,038.218,862,740,506.35
所有者权益(或股东权益):
实收资本(或股本)598,875,685598,855,596598,851,553597,203,812
其他权益工具59,434,549.5959,487,050.7759,497,671.2463,823,408.33
资本公积1,181,174,009.831,182,193,414.271,182,481,618.131,159,504,117.24
其他综合收益5,196,782.564,678,354.644,215,256.593,299,354.86
盈余公积115,933,980.61115,933,980.61115,933,980.61115,933,980.61
未分配利润2,330,878,937.812,371,760,838.072,362,944,127.122,340,340,319.09
归属于母公司股东权益平衡项目0000
归属于母公司股东权益合计4,291,493,945.44,332,909,234.364,323,924,206.694,280,104,992.13
少数股东权益1,214,457,425.781,180,205,973.511,192,186,978.191,167,147,781.29
股东权益平衡项目0000
股东权益合计5,505,951,371.185,513,115,207.875,516,111,184.885,447,252,773.42
负债和股东权益合计14,361,164,907.9314,497,796,871.714,405,956,223.0914,309,993,279.77
公告日期2024-10-302024-08-292024-04-272024-04-27
审计意见(境内)标准无保留意见
TOP↑